Close

ADMA Biologics (ADMA) PT Raised to $12 at Maxim Group Jul 26, 2018 02:16PM
ADMA Biologics (ADMA) PT Raised to $10 at Maxim Group Apr 24, 2018 11:06AM
ADMA Biologics (ADMA) PT Lowered to $8 at Maxim Group To Adjust For Dilution Following Completed Equity Offering in November Dec 12, 2017 08:08AM
Maxim Group Upgrades ADMA Biologics (ADMA) to Buy Jan 23, 2017 02:43PM
Maxim Group Downgrades ADMA Biologics (ADMA) to Hold Following CRL Aug 1, 2016 06:45AM


May 3, 2016 10:47AM ADMA Biologics Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
Apr 28, 2016 09:16AM ADMA Biologics (ADMA) Prices 1.89M Common Stock Offering at $6.50/Share
Apr 28, 2016 09:15AM ADMA Biologics Announces Pricing of Public Offering of Common Stock
Jul 31, 2015 02:28PM Maxim Group Keeps ADMA Biologics (ADMA) at 'Buy' Following RI-002 BLA Submission; Sees Approval in Q316
Mar 18, 2015 10:30AM ADMA Biologics Announces Closing of Public Offering of Common Stock and Exercise of Over-Allotment Option in Full
Mar 13, 2015 09:22AM Adma Biologics (ADMA) Prices 1.23M Common Offering for Proceeds of $9.8M
Mar 13, 2015 09:21AM ADMA Biologics Announces Pricing of Public Offering of Common Stock
Mar 13, 2015 09:21AM ADMA Biologics Announces Pricing of Public Offering of Common Stock
Dec 1, 2014 07:05AM ADMA Biologics (ADMA) PT Raised to $18 at Maxim Group
Dec 2, 2013 08:31AM Maxim Group Starts ADMA Biologics (ADMA) at Buy